These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 9824685)
21. To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a mu opioid agonist influence noxiously evoked c-Fos expression in the rat? A pharmacological study. Honoré P; Chapman V; Buritova J; Besson JM J Pharmacol Exp Ther; 1996 Jul; 278(1):393-403. PubMed ID: 8764375 [TBL] [Abstract][Full Text] [Related]
22. Physiological contributions of neurokinin 1 receptor activation, and interactions with NMDA receptors, to inflammatory-evoked spinal c-Fos expression. Chapman V; Buritova J; Honoré P; Besson JM J Neurophysiol; 1996 Sep; 76(3):1817-27. PubMed ID: 8890294 [TBL] [Abstract][Full Text] [Related]
23. The contribution of supraspinal, peripheral and intrinsic spinal circuits to the pattern and magnitude of Fos-like immunoreactivity in the lumbar spinal cord of the rat withdrawing from morphine. Rohde DS; McKay WR; Chang DS; Abbadie C; Basbaum AI Neuroscience; 1997 Sep; 80(2):599-612. PubMed ID: 9284361 [TBL] [Abstract][Full Text] [Related]
24. Morphine or U-50,488 suppresses Fos protein-like immunoreactivity in the spinal cord and nucleus tractus solitarii evoked by a noxious visceral stimulus in the rat. Hammond DL; Presley R; Gogas KR; Basbaum AI J Comp Neurol; 1992 Jan; 315(2):244-53. PubMed ID: 1545011 [TBL] [Abstract][Full Text] [Related]
25. Enhanced effects of co-administered dexamethasone and diclofenac on inflammatory pain processing and associated spinal c-Fos expression in the rat. Buritova J; Honoré P; Chapman V; Besson JM Pain; 1996 Mar; 64(3):559-568. PubMed ID: 8783322 [TBL] [Abstract][Full Text] [Related]
26. Formalin-evoked Fos expression in spinal cord is enhanced in morphine-tolerant rats. Rohde DS; Detweiler DJ; Basbaum AI Brain Res; 1997 Aug; 766(1-2):93-100. PubMed ID: 9359591 [TBL] [Abstract][Full Text] [Related]
27. Effects of intrathecal BAM22 on noxious stimulus-evoked c-fos expression in the rat spinal dorsal horn. Zeng X; Huang H; Hong Y Brain Res; 2004 Dec; 1028(2):170-9. PubMed ID: 15527742 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of noxious stimulus-evoked pain behaviors and neuronal fos-like immunoreactivity in the spinal cord of the rat by supraspinal morphine. Gogas KR; Cho HJ; Botchkina GI; Levine JD; Basbaum AI Pain; 1996 Apr; 65(1):9-15. PubMed ID: 8826484 [TBL] [Abstract][Full Text] [Related]
29. Effect of administration of high dose intrathecal clonidine or morphine prior to sciatic nerve section on c-Fos expression in rat lumbar spinal cord. Luo L; Ji RR; Zhang Q; Iadarola MJ; Hökfelt T; Wiesenfeld-Hallin Z Neuroscience; 1995 Oct; 68(4):1219-27. PubMed ID: 8544995 [TBL] [Abstract][Full Text] [Related]
30. Reduction of carrageenin oedema and the associated c-Fos expression in the rat lumbar spinal cord by nitric oxide synthase inhibitor. Honoré P; Chapman V; Buritova J; Besson JM Br J Pharmacol; 1995 Jan; 114(1):77-84. PubMed ID: 7536097 [TBL] [Abstract][Full Text] [Related]
31. Morphine priming in rats with chronic inflammation reveals a dichotomy between antihyperalgesic and antinociceptive properties of deltorphin. Gendron L; Esdaile MJ; Mennicken F; Pan H; O'Donnell D; Vincent JP; Devi LA; Cahill CM; Stroh T; Beaudet A Neuroscience; 2007 Jan; 144(1):263-74. PubMed ID: 17055663 [TBL] [Abstract][Full Text] [Related]
32. Lipoxin A4 analog attenuates morphine antinociceptive tolerance, withdrawal-induced hyperalgesia, and glial reaction and cytokine expression in the spinal cord of rat. Jin H; Li YH; Xu JS; Guo GQ; Chen DL; Bo Y Neuroscience; 2012 Apr; 208():1-10. PubMed ID: 22366510 [TBL] [Abstract][Full Text] [Related]
33. Aspirin and acetaminophen reduced both Fos expression in rat lumbar spinal cord and inflammatory signs produced by carrageenin inflammation. Honoré P; Buritova J; Besson JM Pain; 1995 Dec; 63(3):365-375. PubMed ID: 8719538 [TBL] [Abstract][Full Text] [Related]
34. Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by (+)-HA966, a functional NMDA receptor antagonist: a c-Fos study in the rat spinal cord. Buritova J; Le Guen S; Fournié-Zaluski MC; Roques BP; Besson JM Eur J Pain; 2003; 7(3):241-9. PubMed ID: 12725847 [TBL] [Abstract][Full Text] [Related]
35. Intravenous morphine does not modify dorsal horn touch-evoked allodynia in the mononeuropathic rat: a Fos study. Catheline G; Le Guen S; Besson JM Pain; 2001 Jun; 92(3):389-398. PubMed ID: 11376912 [TBL] [Abstract][Full Text] [Related]
36. Concomitant administration of morphine and an N-methyl-D-aspartate receptor antagonist profoundly reduces inflammatory evoked spinal c-Fos expression. Honoré P; Chapman V; Buritova J; Besson JM Anesthesiology; 1996 Jul; 85(1):150-60. PubMed ID: 8694361 [TBL] [Abstract][Full Text] [Related]
37. The contribution of peripheral 5-hydroxytryptamine2A receptor to carrageenan-evoked hyperalgesia, inflammation and spinal Fos protein expression in the rat. Wei H; Chen Y; Hong Y Neuroscience; 2005; 132(4):1073-82. PubMed ID: 15857711 [TBL] [Abstract][Full Text] [Related]
38. Endomorphin-2, deltorphin II and their analogs suppress formalin-induced nociception and c-Fos expression in the rat spinal cord. Labuz D; Chocyk A; Wedzony K; Toth G; Przewlocka B Life Sci; 2003 Jun; 73(4):403-12. PubMed ID: 12759135 [TBL] [Abstract][Full Text] [Related]
39. Tolerance to the antinociceptive properties of morphine in the rat spinal cord: alteration of calcitonin gene-related peptide-like immunostaining and receptor binding sites. Ménard DP; van Rossum D; Kar S; Jolicoeur FB; Jhamandas K; Quirion R J Pharmacol Exp Ther; 1995 May; 273(2):887-94. PubMed ID: 7752094 [TBL] [Abstract][Full Text] [Related]
40. Antisense oligonucleotide knockdown of mGlu₅ receptor attenuates the antinociceptive tolerance and up-regulated expression of spinal protein kinase C associated with chronic morphine treatment. Xu T; Chen M; Zhou Q; Xue Y; Wang L; Bil De Arce VJ; Zhang X; Jiang W Eur J Pharmacol; 2012 May; 683(1-3):78-85. PubMed ID: 22429573 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]